Survival benefit of repeat resection of successive recurrences after the initial hepatic resection for colorectal liver metastases

Surgery (United States)

Volumn 159, Issue 2, 2016, Pages 632-640

  Oba, Masaru ^a   Hasegawa, Kiyoshi ^a   Shindoh, Junichi ^a   Yamashita, Suguru ^a   Sakamoto, Yoshihiro ^a   Makuuchi, Masatoshi ^b   Kokudo, Norihiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPANESE RED CROSS MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL LIVER METASTASIS; FEMALE; HAZARD RATIO; HUMAN; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS RESECTION; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; REOPERATION; SURVIVAL RATE; SURVIVAL TIME; ADENOCARCINOMA; COLORECTAL TUMOR; COMPARATIVE STUDY; EVALUATION STUDY; FOLLOW UP; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; SECONDARY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR RECURRENCE; VERY ELDERLY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; REOPERATION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84954518593     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2015.09.003     Document Type: Article

References (26)

1. R. Stangl, A. Altendorf-Hofmann, R.M. Charnley, and J. Scheele Factors influencing the natural history of colorectal liver metastases Lancet 343 1994 1405 1410
2. S. Kopetz, G.J. Chang, M.J. Overman, C. Eng, D.J. Sargent, D.W. Larson, and et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy J Clin Oncol 27 2009 3677 3683
3. M.C. de Jong, C. Pulitano, D. Ribero, J. Strub, G. Mentha, R.D. Schulick, and et al. Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients Ann Surg 250 2009 440 448
4. A. Andres, C. Toso, R. Adam, E. Barroso, C. Hubert, L. Capussotti, and et al. A survival analysis of the liver-first reversed management of advanced simultaneous colorectal liver metastases: a LiverMetSurvey-based study Ann Surg 256 2012 772 778
5. T. Beppu, Y. Sakamoto, K. Hasegawa, G. Honda, K. Tanaka, Y. Kotera, and et al. A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery J Hepatobiliary Pancreat Sci 19 2012 72 84
6. A. Saiura, J. Yamamoto, K. Hasegawa, R. Koga, Y. Sakamoto, S. Hata, and et al. Liver resection for multiple colorectal liver metastases with surgery up-front approach: bi-institutional analysis of 736 consecutive cases World J Surg 36 2012 2171 2178
7. Y. Mise, H. Imamura, T. Hashimoto, Y. Seyama, T. Aoki, K. Hasegawa, and et al. Cohort study of the survival benefit of resection for recurrent hepatic and/or pulmonary metastases after primary hepatectomy for colorectal metastases Ann Surg 251 2010 902 909
8. G. Portier, D. Elias, O. Bouche, O. Bouche, P. Rougier, J.F. Bosset, and et al. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial J Clin Oncol 24 2006 4976 4982
9. E. Mitry, A.L. Fields, H. Bleiberg, R. Labianca, G. Portier, D. Tu, and et al. Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials J Clin Oncol 26 2008 4906 4911
10. M. Ychou, W. Hohenberger, S. Thezenas, M. Navarro, J. Maurel, C. Bokemeyer, and et al. A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer Ann Oncol 20 2009 1964 1970
11. B. Nordlinger, H. Sorbye, B. Glimelius, G.J. Poston, P.M. Schlag, P. Rougier, and et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Lancet 371 2008 1007 1016
12. B. Nordlinger, H. Sorbye, B. Glimelius, G.J. Poston, P.M. Schlag, P. Rougier, and et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial Lancet Oncol 14 2013 1208 1215
13. R. Adam, G. Pascal, D. Azoulay, K. Tanaka, D. Castaing, H. Bismuth, and et al. Liver resection for colorectal metastases: the third hepatectomy Ann Surg 238 2003 871 883
14. D.A. Wicherts, R.J. de Haas, C. Salloum, P. Andreani, G. Pascal, D. Sotirov, and et al. Repeat hepatectomy for recurrent colorectal metastases Br J Surg 100 2013 808 818
15. U. Kulik, H. Bektas, J. Klempnauer, and F. Lehner Repeat liver resection for colorectal metastases Br J Surg 100 2013 926 932
16. S. Yamazaki, T. Takayama, S. Okada, A. Iwama, Y. Midorikawa, M. Moriguchi, and et al. Good candidates for a third liver resection of colorectal metastasis World J Surg 37 2013 847 853
17. N. Kokudo, K. Hasegawa, and M. Makuuchi Control arm for surgery alone is needed but difficult to obtain in randomized trials for adjuvant chemotherapy after liver resection for colorectal metastases J Clin Oncol 25 2007 1299 1300 author reply 1300
18. M. Takahashi, K. Hasegawa, J. Arita, S. Hata, T. Aoki, Y. Sakamoto, and et al. Contrast-enhanced intraoperative ultrasonography using perfluorobutane microbubbles for the enumeration of colorectal liver metastases Br J Surg 99 2012 1271 1277
19. E.K. Abdalla Commentary: Radiofrequency ablation for colorectal liver metastases: do not blame the biology when it is the technology Am J Surg 197 2009 737 739
20. P.A. Clavien, J. Barkun, M.L. de Oliveira, J.N. Vauthey, D. Dindo, R.D. Schulick, and et al. The Clavien-Dindo classification of surgical complications: five-year experience Ann Surg 250 2009 187 196
21. A. Saiura, J. Yamamoto, R. Koga, Y. Takahashi, M. Tkahashi, Y. Inoue, and et al. Favorable outcome after repeat resection for colorectal liver metastases Ann Surg Oncol 21 2014 4293 4299
22. E. Van Cutsem, C.H. Köhne, I. Láng, G. Folprecht, M.P. Nowacki, S. Cascinu, and et al. Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status J Clin Oncol 29 2011 2011 2019
23. J.Y. Douillard, K.S. Oliner, S. Siena, J. Tabernero, R. Burkes, M. Barugel, and et al. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer N Engl J Med 369 2013 1023 1034
24. J. Bennouna, J. Sastre, D. Arnold, P. Österlund, R. Greil, E. Van Cutsem, and et al. Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial Lancet Oncol 14 2013 29 37
25. V. Heinemann, L.F. von Weikersthal, T. Decker, A. Kiani, U. Vehling-Kaiser, S.E. Al-Batran, and et al. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial Lancet Oncol 15 2014 1065 1075
26. M. Oba, K. Hasegawa, Y. Matsuyama, J. Shindoh, Y. Mise, T. Aoki, and et al. Discrepancy between recurrence-free survival and overall survival in patients with resectable colorectal liver metastases: a potential surrogate endpoint for time to surgical failure Ann Surg Oncol 21 2014 1817 1824